Author:
Tang Yuqing,Zhang Xiaopeng,Yang Chunyan,Yang Lianping,Wang Hongtao,Zhang Xinping
Abstract
Abstract
Background
The problem posed by therapeutic injection is a clinical practice issue that influences health care quality and patient safety. Although sufficient government subsidy was one of the 12 key interventions to promote rational drug use initiated by WHO (World Health Organization), limited information is available about the association between government subsidy and injection use in primary health care institutions. In 2009, National Essential Medicines System (NEMS) was implemented in China. The subsidy policy plays an important role in maintaining primary health care institutions. This study explores the impact of government subsidies on the injection use in primary health care institutions in China.
Methods
126 primary health institutions were included in this study. Institutions were divided into two groups (intervention and control groups) according to the median GS (General subsidy per personnel). Propensity score matching (PSM) was used to minimize the observed covariate differences in the characteristics of the primary institutions between the two groups. Kappa score was calculated to determine the consistency between the groups. Paired chi-square test and Relative Risk (RR) were calculated to compare the differences in injection use between the groups.
Results
Among all the investigated prescriptions, the overall percent of people who received an injection prescribed was 36.96% (n = 12600). PSM showed no significant covariate difference among the 34 groups obtained through this analysis. Kappa score (k = −0.082, p = 0.558) indicated an inconsistency between groups and paired chi-square test revealed a significant difference (p < 0.05) in injection use between the two groups. Relative Risk = 0.679 (95%CI [0.485, 0.950]) indicate that high General subsidy per personnel is a protective factor for primary health care institutions to prescribe injections properly. The intervention group obtained a higher possibility of using injection properly.
Conclusions
The overall effect of government subsidy on the use of injection was positively significant. However, the mechanism by which government subsidy influence injection administration remains unclear, and thus requires further study.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Wachter R: Patient safety at 10 years: how far have we come? What’s next?. OR Manager. 2010, 3 (1): 5-7.
2. Dickey NW, Corrigan JM, Denham CR: Ten-year retrospective review. J Patient Safe. 2010, 6 (1): 1-4. 10.1097/PTS.0b013e3181d321ca.
3. Organization WH: Safety of injections: Global facts and figures. 2004, Geneva: World Health Organization
4. Li Y, Xu J, Wang F, Wang B, Liu L, Hou W, Fan H, Tong Y, Zhang J, Lu Z: Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood). 2012, 31 (5): 1075-1082. 10.1377/hlthaff.2010.0965.
5. Huang N, Chou YJ, Chang HJ, Ho M, Morlock L: Antibiotic prescribing by ambulatory care physicians for adults with nasopharyngitis, URIs, and acute bronchitis in Taiwan: a multi-level modeling approach. Fam Pract. 2005, 22 (2): 160-167. 10.1093/fampra/cmh734.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献